Vivus Shares Surge After FDA Panel Backs Diet Drug shares jump 78% on backing of Qnexa approval may pave way for another antiobesity drug panel recommends new diet New Promises 10% Weight Loss At What Price FDA's Nod Sparks Praise Criticism soar after vote obesity Use Caution Vivus' Victory WeightLoss OKs previously rejected weightloss pill advisors endorse 1st in 13 years gets initial OK should be approved says

New Diet Drug Qnexa Promises 10% Weight Loss - At What Price? Qnexa could be the next hit diet drug, helping people lose up to 10 percent of their body weight. But even if approved by the FDA, is it really safe, or could it cause heart damage like Phen-Fen before it? FDA advisors endorse weight-loss drug Qnexa A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999. Qnexa: As Diet Drug Nears FDA Approval, Who Benefits? For the first time in 13 years, a new prescription weight-loss pill appears poised to hit the U.S. market. Vivus Gains After Panel Backs Its Qnexa Weight-Loss Pill Vivus Inc. gained the most in 12 years after the company's pill Qnexa won the backing of a regulatory panel, moving the drug a step closer to gaining U.S. approval as the first new obesity treatment in 13 years. FDA Panel Votes in Favor of Weight Loss Pill Qnexa Title: FDA Panel Votes in Favor of Weight Loss Pill Qnexa Category: Health News Created: 2/23/2012 11:00:00 AM Last Editorial Review: 2/23/2012 Qnexa approval may pave way for another obesity drug An FDA advisory committee's endorsement of the anti-obesity drug Qnexa Wednesday could re-energized the pharmaceutical industry after several years of disappointment in trying to develop anti-obesity drugs. The committee voted 20 to 2 to recommend approval of Qnexa, which is a combination of two existing drugs, the appetite suppressant phentermine and the anti-seizure medication topiramate. The ... FDA's Qnexa Nod Sparks Praise, Criticism The decision by a federal advisory panel on Wednesday to recommend Qnexa for approval by the U.S. Food and Drug Administration is drawing praise and criticism from obesity and diet experts, reflecting a still-hot debate on the need for additional tools to treat obesity. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel Vivus Inc.'s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. The shares doubled in late trading. Panel recommends FDA OK obesity drug Qnexa Experimental obesity drug Qnexa won the backing of U.S. health advisers, raising hopes for approval of the first prescription weight-loss pill in 13 years. Diet drug Qnexa should be approved, panel says The diet drug Qnexa has cleared a major hurdle toward eventual Food and Drug Administration approval. An independent panel of medical experts who advise the agency voted Wednesday that Qnexa's significant weight-loss benefit outweighed its potential risks.
Key Words: qnexa

References:
http://online.wsj.com/article/SB10001424052970203960804577241220152561402.html?mod=rss_whats_news_us
http://feeds.sfgate.com/click.phdo?i=95ce7de21d4d669c93b7e66245fc5625
http://feeds.abcnews.com/click.phdo?i=db73224251df898820737445b71bacb7
http://feeds.bizjournals.com/~r/vertical_38/~3/o_AgxLZpWCs/vivus-obesity-fda-qnexa.html
http://www.forbes.com/sites/matthewherper/2012/02/23/use-caution-after-vivus-victory/
http://online.wsj.com/article/SB10001424052970203960804577239642544675320.html?mod=rss_whats_news_us
http://feedproxy.google.com/~r/orlandosentinel/news/local/southwest/~3/Qg4sLpAyIGc/sns-bc-us--dietpill-fdameeting,0,6216893.story
http://pixelhat.net/